Q&A: Focus on myelodysplastic syndromes
A growing incidence of myelodysplastic syndromes (MDS), mostly in older adults, has sent researchers and clinicians scrambling for answers to the biology and treatment of this group of serious blood disorders.
Below, Guillermo Garcia-Manero, M.D., answers questions about MDS.
What is MDS?
It's a very complex group of hematological disorders characterized by progressive peripheral blood...
Q&A: Minimally invasive surgery for cancer patients
Just a few years ago, most surgeries were "open," or invasive, procedures in which a surgeon made a large incision while the surgery...
Q&A: Cardiac catheterization for cancer patients
A cardiac catheterization laboratory contains specialized technology that benefits cancer patients when they need more thorough cardiac evaluations...
Q&A: Intravenous busulfan before stem cell transplant
The invention of IV Busulfex™ (the intravenous formulation of busulfan) has contributed to a dramatic change in the standard of care for patients undergoing stem cell transplantation for leukemia. It also has greatly improved the outlook for patients with hematologic (blood) and lymphoid cancers.
In March, the lead inventor, Borje S. Andersson, M.D., Ph.D., professor in MD Anderson's Department of Stem Cell Transplantation...
Q&A: Proton therapy for pediatric patients
Anita Mahajan, M.D., associate professor in Radiation Oncology, answers questions about proton therapy for pediatric cancer patients.
...
Race and ethnicity as cancer risk factors
As we acknowledge National Minority Cancer Awareness Week, it's an appropriate time to pause to look at why race and ethnicity might be risk...
Q&A: Thyroid cancer
Thyroid cancer is a disease in which cancer cells are found in the tissue of the thyroid gland.
Camilo Jimenez, M.D., assistant professor...